Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

P&G Appeals NAD Decision On “Dentist-Recommended” Crest Pro-Health Ad

This article was originally published in The Tan Sheet

Executive Summary

Procter & Gamble intends to appeal the National Advertising Division's conclusion the firm should modify ads suggesting its Crest Pro-Health toothpaste is recommended for use by dentists

You may also be interested in...



Colgate Optic White Comparison To P&G Whitestrips Off Target – NAD

NAD says Colgate provided “insufficiently reliable” evidence to support the claim “Same Whitening Ingredient As Strips” on packaging for Optic White toothpaste. But, the Council of Better Business Bureaus division finds Colgate supported a claim that Optic White “removes stains that non-whitening fluoride toothpastes do not.”

Colgate Optic White Comparison To P&G Whitestrips Off Target – NAD

NAD says Colgate provided “insufficiently reliable” evidence to support the claim “Same Whitening Ingredient As Strips” on packaging for Optic White toothpaste. But, the Council of Better Business Bureaus division finds Colgate supported a claim that Optic White “removes stains that non-whitening fluoride toothpastes do not.”

P&G Faces Proposed Class-Action Alleging Fraud Over Crest Pro-Health Rinse

A proposed class-action lawsuit alleges Procter & Gamble failed to warn consumers that its Crest Pro-Health Rinse may stain teeth and impair the sense of taste

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS100642

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel